Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Inflammatory Breast Neoplasms × Early Intervention, Educational × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Multiple Myeloma 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Head and Neck Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Tobacco Use Disorder 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sleep Wake Disorders 1 Sleep Initiation and Maintenance Disorders 1 Sezary Syndrome 1 Prostate Adenocarcinoma 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pain 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms, Plasma Cell 1

Interventions

Cyclophosphamide 11 Doxorubicin 7 Trastuzumab 6 Paclitaxel 6 Taxes 5 Radiotherapy 4 Epirubicin 4 Docetaxel 4 Carboplatin 4 Albumin-Bound Paclitaxel 4 pembrolizumab 3 Melphalan 3 pertuzumab 2 eribulin 2 Thiotepa 2 Tamoxifen 2 Peripheral Blood Stem Cell Transplantation 2 Lapatinib 2 Fluorouracil 2 Filgrastim 2 130-nm albumin-bound paclitaxel 2 trastuzumab biosimilar HLX02 1 talimogene laherparepvec 1 sargramostim 1 ruxolitinib 1 romidepsin 1 pazopanib 1 nintedanib 1 neratinib 1 grapiprant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡